Alx Oncology Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Alx Oncology Stock Summary

Alx Oncology competes with Cabaletta Bio, Viracta Therapeutics, Eyepoint Pharmaceuticals, Biomea Fusion, and Crinetics Pharmaceuticals. ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. The company was founded in 2015 and is headquartered in South San Francisco, California. Alx Oncology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.

Alx Oncology Key Financial Ratios

Alx Oncology Key Balance Sheet Accounts

Alx Oncology Key Income Statement Accounts

Alx Oncology Key Cash Accounts

Alx Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alx Oncology's current stock value. Our valuation model uses many indicators to compare Alx Oncology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alx Oncology competition to find correlations between indicators driving Alx Oncology's intrinsic value. More Info.Alx Oncology Holdings is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Alx Oncology's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alx Oncology's earnings, one of the primary drivers of an investment's value.

Alx Oncology Holdings Systematic Risk

Today, most investors in Alx Oncology Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alx Oncology's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Alx Oncology growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Alx Oncology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alx Oncology Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alx Oncology Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Alx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alx Oncology's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alx Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Alx Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alx Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alx Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.